Mycoplasma Testing - Global Market Outlook (2016-2022)

February 2017 | 153 pages | ID: M486C78D219EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Mycoplasma Testing market is accounted for $427.2 million in 2016 and is expected to reach $911.7 million by 2022 growing at a CAGR of 13.5% from 2016 to 2022. Rising R&D investments in life sciences, increasing healthcare expenditure levels, increased number of patients suffering from infectious diseases, rapidly increasing new drug launches, increasing applications of PCR technologies in the field of life science, growing biotechnology & pharmaceutical companies, technological advancements and increasing government support are some of the factors favouring the mycoplasma testing market. However, stringent government regulations and high degree of consolidation for new entrants are hampering the market.

Polymerase Chain Reaction (PCR) technology is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. In 2016, kits & reagents products accounted for the largest market share due to repeated purchase of these products. Pharmaceutical and biotechnology companies hold the largest share in end users segment. Contract research organizations are anticipated to grow at a faster pace during the forecast period.

North America is the largest market for mycoplasma testing market due to increasing demand for fast, accurate and affordable diagnosis in healthcare. In addition, spending in R&D activities is expected to enhance developments and rising government funding for pharmaceutical and biotechnology sector in North America is also boosting the growth of mycoplasma testing markets. Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, funding initiatives generated by the Indian government to promote R&D activities in biopharmaceutical industries.

Some of the significant players in global mycoplasma testing market are Abbott, American Type Culture Collection, Beckman Coulter/Danaher, Becton Dickinson, Biological Industries, Israel Beit Haemek Ltd., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Promo Cell GmbH, Qiagen, Roche, Sigma-Aldrich and Thermo Fisher Scientific, Inc.

Technologies Covered:

• Direct Assay
• Enzymatic Methods
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Indirect Assay
• Microbial Culture Techniques
• Polymerase Chain Reaction (PCR)

Product Types Covered:

• Services
• Instruments
• Kits & Reagents
• Elimination Kits & Reagents
• Nucleic Acid Detection Kits
• PCR Assays
• Stains
• Standards & Controls
• Other Kits & Reagents

Applications Covered:

• Virus Testing
• End of Production Cells Testing
• Cell Line Testing
• Other Applications

End Users Covered:

• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Other End Users

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNOLOGY

5.1 Introduction
5.2 Direct Assay
5.3 Enzymatic Methods
5.4 Enzyme-Linked Immunosorbent Assay (ELISA)
5.5 Indirect Assay
5.6 Microbial Culture Techniques
5.7 Polymerase Chain Reaction (PCR)

6 GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT TYPE

6.1 Introduction
6.2 Services
6.3 Instruments
6.4 Kits & Reagents
  6.4.1 Elimination Kits & Reagents
  6.4.2 Nucleic Acid Detection Kits
  6.4.3 PCR Assays
  6.4.4 Stains
  6.4.5 Standards & Controls
  6.4.6 Other Kits & Reagents

7 GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION

7.1 Introduction
7.2 Virus Testing
7.3 End of Production Cells Testing
7.4 Cell Line Testing
7.5 Other Applications

8 GLOBAL MYCOPLASMA TESTING MARKET, BY END USER

8.1 Introduction
8.2 Academic Research Institutes
8.3 Cell Banks
8.4 Contract Research Organizations
8.5 Pharmaceutical & Biotechnology Companies
8.6 Other End Users

9 GLOBAL MYCOPLASMA TESTING MARKET, BY GEOGRAPHY

9.1 North America
  9.1.1 US
  9.1.2 Canada
  9.1.3 Mexico
9.2 Europe
  9.2.1 Germany
  9.2.2 France
  9.2.3 Italy
  9.2.4 UK
  9.2.5 Spain
  9.2.6 Rest of Europe
9.3 Asia Pacific
  9.3.1 Japan
  9.3.2 China
  9.3.3 India
  9.3.4 Australia
  9.3.5 New Zealand
  9.3.6 Rest of Asia Pacific
9.4 Rest of the World
  9.4.1 Middle East
  9.4.2 Brazil
  9.4.3 Argentina
  9.4.4 South Africa
  9.4.5 Egypt

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 Abbott
11.2 American Type Culture Collection
11.3 Beckman Coulter/Danaher
11.4 Becton Dickinson
11.5 Biological Industries Israel Beit Haemek Ltd.
11.6 Bionique Testing Laboratories, Inc.
11.7 Charles River Laboratories International, Inc.
11.8 InvivoGen
11.9 Lonza Group Ltd.
11.10 Merck KGaA
11.11 Promo Cell GmbH
11.12 Qiagen
11.13 Roche
11.14 Sigma-Aldrich
11.15 Thermo Fisher Scientific, Inc.

List Of Tables

LIST OF TABLES

Table 1 Global Mycoplasma Testing Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Mycoplasma Testing Market Outlook, By Technology (2014-2022) ($MN)
Table 3 Global Mycoplasma Testing Market Outlook, By Direct Assay (2014-2022) ($MN)
Table 4 Global Mycoplasma Testing Market Outlook, By Enzymatic Methods (2014-2022) ($MN)
Table 5 Global Mycoplasma Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2022) ($MN)
Table 6 Global Mycoplasma Testing Market Outlook, By Indirect Assay (2014-2022) ($MN)
Table 7 Global Mycoplasma Testing Market Outlook, By Microbial Culture Techniques (2014-2022) ($MN)
Table 8 Global Mycoplasma Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2014-2022) ($MN)
Table 9 Global Mycoplasma Testing Market Outlook, By Product Type (2014-2022) ($MN)
Table 10 Global Mycoplasma Testing Market Outlook, By Services (2014-2022) ($MN)
Table 11 Global Mycoplasma Testing Market Outlook, By Instruments (2014-2022) ($MN)
Table 12 Global Mycoplasma Testing Market Outlook, By Kits & Reagents (2014-2022) ($MN)
Table 13 Global Mycoplasma Testing Market Outlook, By Elimination Kits & Reagents (2014-2022) ($MN)
Table 14 Global Mycoplasma Testing Market Outlook, By Nucleic Acid Detection Kits (2014-2022) ($MN)
Table 15 Global Mycoplasma Testing Market Outlook, By PCR Assays (2014-2022) ($MN)
Table 16 Global Mycoplasma Testing Market Outlook, By Stains (2014-2022) ($MN)
Table 17 Global Mycoplasma Testing Market Outlook, By Standards & Controls (2014-2022) ($MN)
Table 18 Global Mycoplasma Testing Market Outlook, By Other Kits & Reagents (2014-2022) ($MN)
Table 19 Global Mycoplasma Testing Market Outlook, By Application (2014-2022) ($MN)
Table 20 Global Mycoplasma Testing Market Outlook, By Virus Testing (2014-2022) ($MN)
Table 21 Global Mycoplasma Testing Market Outlook, By End of Production Cells Testing (2014-2022) ($MN)
Table 22 Global Mycoplasma Testing Market Outlook, By Cell Line Testing (2014-2022) ($MN)
Table 23 Global Mycoplasma Testing Market Outlook, By Other Applications (2014-2022) ($MN)
Table 24 Global Mycoplasma Testing Market Outlook, By End User (2014-2022) ($MN)
Table 25 Global Mycoplasma Testing Market Outlook, By Academic Research Institutes (2014-2022) ($MN)
Table 26 Global Mycoplasma Testing Market Outlook, By Cell Banks (2014-2022) ($MN)
Table 27 Global Mycoplasma Testing Market Outlook, By Contract Research Organizations (2014-2022) ($MN)
Table 28 Global Mycoplasma Testing Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2022) ($MN)
Table 29 Global Mycoplasma Testing Market Outlook, By Other End Users (2014-2022) ($MN)
Table 30 North America Mycoplasma Testing Market Outlook, By Country (2014-2022) ($MN)
Table 31 North America Mycoplasma Testing Market Outlook, By Technology (2014-2022) ($MN)
Table 32 North America Mycoplasma Testing Market Outlook, By Direct Assay (2014-2022) ($MN)
Table 33 North America Mycoplasma Testing Market Outlook, By Enzymatic Methods (2014-2022) ($MN)
Table 34 North America Mycoplasma Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2022) ($MN)
Table 35 North America Mycoplasma Testing Market Outlook, By Indirect Assay (2014-2022) ($MN)
Table 36 North America Mycoplasma Testing Market Outlook, By Microbial Culture Techniques (2014-2022) ($MN)
Table 37 North America Mycoplasma Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2014-2022) ($MN)
Table 38 North America Mycoplasma Testing Market Outlook, By Product Type (2014-2022) ($MN)
Table 39 North America Mycoplasma Testing Market Outlook, By Services (2014-2022) ($MN)
Table 40 North America Mycoplasma Testing Market Outlook, By Instruments (2014-2022) ($MN)
Table 41 North America Mycoplasma Testing Market Outlook, By Kits & Reagents (2014-2022) ($MN)
Table 42 North America Mycoplasma Testing Market Outlook, By Elimination Kits & Reagents (2014-2022) ($MN)
Table 43 North America Mycoplasma Testing Market Outlook, By Nucleic Acid Detection Kits (2014-2022) ($MN)
Table 44 North America Mycoplasma Testing Market Outlook, By PCR Assays (2014-2022) ($MN)
Table 45 North America Mycoplasma Testing Market Outlook, By Stains (2014-2022) ($MN)
Table 46 North America Mycoplasma Testing Market Outlook, By Standards & Controls (2014-2022) ($MN)
Table 47 North America Mycoplasma Testing Market Outlook, By Other Kits & Reagents (2014-2022) ($MN)
Table 48 North America Mycoplasma Testing Market Outlook, By Application (2014-2022) ($MN)
Table 49 North America Mycoplasma Testing Market Outlook, By Virus Testing (2014-2022) ($MN)
Table 50 North America Mycoplasma Testing Market Outlook, By End of Production Cells Testing (2014-2022) ($MN)
Table 51 North America Mycoplasma Testing Market Outlook, By Cell Line Testing (2014-2022) ($MN)
Table 52 North America Mycoplasma Testing Market Outlook, By Other Applications (2014-2022) ($MN)
Table 53 North America Mycoplasma Testing Market Outlook, By End User (2014-2022) ($MN)
Table 54 North America Mycoplasma Testing Market Outlook, By Academic Research Institutes (2014-2022) ($MN)
Table 55 North America Mycoplasma Testing Market Outlook, By Cell Banks (2014-2022) ($MN)
Table 56 North America Mycoplasma Testing Market Outlook, By Contract Research Organizations (2014-2022) ($MN)
Table 57 North America Mycoplasma Testing Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2022) ($MN)
Table 58 North America Mycoplasma Testing Market Outlook, By Other End Users (2014-2022) ($MN)
Table 59 Europe Mycoplasma Testing Market Outlook, By Country (2014-2022) ($MN)
Table 60 Europe Mycoplasma Testing Market Outlook, By Technology (2014-2022) ($MN)
Table 61 Europe Mycoplasma Testing Market Outlook, By Direct Assay (2014-2022) ($MN)
Table 62 Europe Mycoplasma Testing Market Outlook, By Enzymatic Methods (2014-2022) ($MN)
Table 63 Europe Mycoplasma Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2022) ($MN)
Table 64 Europe Mycoplasma Testing Market Outlook, By Indirect Assay (2014-2022) ($MN)
Table 65 Europe Mycoplasma Testing Market Outlook, By Microbial Culture Techniques (2014-2022) ($MN)
Table 66 Europe Mycoplasma Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2014-2022) ($MN)
Table 67 Europe Mycoplasma Testing Market Outlook, By Product Type (2014-2022) ($MN)
Table 68 Europe Mycoplasma Testing Market Outlook, By Services (2014-2022) ($MN)
Table 69 Europe Mycoplasma Testing Market Outlook, By Instruments (2014-2022) ($MN)
Table 70 Europe Mycoplasma Testing Market Outlook, By Kits & Reagents (2014-2022) ($MN)
Table 71 Europe Mycoplasma Testing Market Outlook, By Elimination Kits & Reagents (2014-2022) ($MN)
Table 72 Europe Mycoplasma Testing Market Outlook, By Nucleic Acid Detection Kits (2014-2022) ($MN)
Table 73 Europe Mycoplasma Testing Market Outlook, By PCR Assays (2014-2022) ($MN)
Table 74 Europe Mycoplasma Testing Market Outlook, By Stains (2014-2022) ($MN)
Table 75 Europe Mycoplasma Testing Market Outlook, By Standards & Controls (2014-2022) ($MN)
Table 76 Europe Mycoplasma Testing Market Outlook, By Other Kits & Reagents (2014-2022) ($MN)
Table 77 Europe Mycoplasma Testing Market Outlook, By Application (2014-2022) ($MN)
Table 78 Europe Mycoplasma Testing Market Outlook, By Virus Testing (2014-2022) ($MN)
Table 79 Europe Mycoplasma Testing Market Outlook, By End of Production Cells Testing (2014-2022) ($MN)
Table 80 Europe Mycoplasma Testing Market Outlook, By Cell Line Testing (2014-2022) ($MN)
Table 81 Europe Mycoplasma Testing Market Outlook, By Other Applications (2014-2022) ($MN)
Table 82 Europe Mycoplasma Testing Market Outlook, By End User (2014-2022) ($MN)
Table 83 Europe Mycoplasma Testing Market Outlook, By Academic Research Institutes (2014-2022) ($MN)
Table 84 Europe Mycoplasma Testing Market Outlook, By Cell Banks (2014-2022) ($MN)
Table 85 Europe Mycoplasma Testing Market Outlook, By Contract Research Organizations (2014-2022) ($MN)
Table 86 Europe Mycoplasma Testing Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2022) ($MN)
Table 87 Europe Mycoplasma Testing Market Outlook, By Other End Users (2014-2022) ($MN)
Table 88 Asia Pacific Mycoplasma Testing Market Outlook, By Country (2014-2022) ($MN)
Table 89 Asia Pacific Mycoplasma Testing Market Outlook, By Technology (2014-2022) ($MN)
Table 90 Asia Pacific Mycoplasma Testing Market Outlook, By Direct Assay (2014-2022) ($MN)
Table 91 Asia Pacific Mycoplasma Testing Market Outlook, By Enzymatic Methods (2014-2022) ($MN)
Table 92 Asia Pacific Mycoplasma Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2022) ($MN)
Table 93 Asia Pacific Mycoplasma Testing Market Outlook, By Indirect Assay (2014-2022) ($MN)
Table 94 Asia Pacific Mycoplasma Testing Market Outlook, By Microbial Culture Techniques (2014-2022) ($MN)
Table 95 Asia Pacific Mycoplasma Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2014-2022) ($MN)
Table 96 Asia Pacific Mycoplasma Testing Market Outlook, By Product Type (2014-2022) ($MN)
Table 97 Asia Pacific Mycoplasma Testing Market Outlook, By Services (2014-2022) ($MN)
Table 98 Asia Pacific Mycoplasma Testing Market Outlook, By Instruments (2014-2022) ($MN)
Table 99 Asia Pacific Mycoplasma Testing Market Outlook, By Kits & Reagents (2014-2022) ($MN)
Table 100 Asia Pacific Mycoplasma Testing Market Outlook, By Elimination Kits & Reagents (2014-2022) ($MN)
Table 101 Asia Pacific Mycoplasma Testing Market Outlook, By Nucleic Acid Detection Kits (2014-2022) ($MN)
Table 102 Asia Pacific Mycoplasma Testing Market Outlook, By PCR Assays (2014-2022) ($MN)
Table 103 Asia Pacific Mycoplasma Testing Market Outlook, By Stains (2014-2022) ($MN)
Table 104 Asia Pacific Mycoplasma Testing Market Outlook, By Standards & Controls (2014-2022) ($MN)
Table 105 Asia Pacific Mycoplasma Testing Market Outlook, By Other Kits & Reagents (2014-2022) ($MN)
Table 106 Asia Pacific Mycoplasma Testing Market Outlook, By Application (2014-2022) ($MN)
Table 107 Asia Pacific Mycoplasma Testing Market Outlook, By Virus Testing (2014-2022) ($MN)
Table 108 Asia Pacific Mycoplasma Testing Market Outlook, By End of Production Cells Testing (2014-2022) ($MN)
Table 109 Asia Pacific Mycoplasma Testing Market Outlook, By Cell Line Testing (2014-2022) ($MN)
Table 110 Asia Pacific Mycoplasma Testing Market Outlook, By Other Applications (2014-2022) ($MN)
Table 111 Asia Pacific Mycoplasma Testing Market Outlook, By End User (2014-2022) ($MN)
Table 112 Asia Pacific Mycoplasma Testing Market Outlook, By Academic Research Institutes (2014-2022) ($MN)
Table 113 Asia Pacific Mycoplasma Testing Market Outlook, By Cell Banks (2014-2022) ($MN)
Table 114 Asia Pacific Mycoplasma Testing Market Outlook, By Contract Research Organizations (2014-2022) ($MN)
Table 115 Asia Pacific Mycoplasma Testing Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2022) ($MN)
Table 116 Asia Pacific Mycoplasma Testing Market Outlook, By Other End Users (2014-2022) ($MN)
Table 117 RoW Mycoplasma Testing Market Outlook, By Country (2014-2022) ($MN)
Table 118 RoW Mycoplasma Testing Market Outlook, By Technology (2014-2022) ($MN)
Table 119 RoW Mycoplasma Testing Market Outlook, By Direct Assay (2014-2022) ($MN)
Table 120 RoW Mycoplasma Testing Market Outlook, By Enzymatic Methods (2014-2022) ($MN)
Table 121 RoW Mycoplasma Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2022) ($MN)
Table 122 RoW Mycoplasma Testing Market Outlook, By Indirect Assay (2014-2022) ($MN)
Table 123 RoW Mycoplasma Testing Market Outlook, By Microbial Culture Techniques (2014-2022) ($MN)
Table 124 RoW Mycoplasma Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2014-2022) ($MN)
Table 125 RoW Mycoplasma Testing Market Outlook, By Product Type (2014-2022) ($MN)
Table 126 RoW Mycoplasma Testing Market Outlook, By Services (2014-2022) ($MN)
Table 127 RoW Mycoplasma Testing Market Outlook, By Instruments (2014-2022) ($MN)
Table 128 RoW Mycoplasma Testing Market Outlook, By Kits & Reagents (2014-2022) ($MN)
Table 129 RoW Mycoplasma Testing Market Outlook, By Elimination Kits & Reagents (2014-2022) ($MN)
Table 130 RoW Mycoplasma Testing Market Outlook, By Nucleic Acid Detection Kits (2014-2022) ($MN)
Table 131 RoW Mycoplasma Testing Market Outlook, By PCR Assays (2014-2022) ($MN)
Table 132 RoW Mycoplasma Testing Market Outlook, By Stains (2014-2022) ($MN)
Table 133 RoW Mycoplasma Testing Market Outlook, By Standards & Controls (2014-2022) ($MN)
Table 134 RoW Mycoplasma Testing Market Outlook, By Other Kits & Reagents (2014-2022) ($MN)
Table 135 RoW Mycoplasma Testing Market Outlook, By Application (2014-2022) ($MN)
Table 136 RoW Mycoplasma Testing Market Outlook, By Virus Testing (2014-2022) ($MN)
Table 137 RoW Mycoplasma Testing Market Outlook, By End of Production Cells Testing (2014-2022) ($MN)
Table 138 RoW Mycoplasma Testing Market Outlook, By Cell Line Testing (2014-2022) ($MN)
Table 139 RoW Mycoplasma Testing Market Outlook, By Other Applications (2014-2022) ($MN)
Table 140 RoW Mycoplasma Testing Market Outlook, By End User (2014-2022) ($MN)
Table 141 RoW Mycoplasma Testing Market Outlook, By Academic Research Institutes (2014-2022) ($MN)
Table 142 RoW Mycoplasma Testing Market Outlook, By Cell Banks (2014-2022) ($MN)
Table 143 RoW Mycoplasma Testing Market Outlook, By Contract Research Organizations (2014-2022) ($MN)
Table 144 RoW Mycoplasma Testing Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2022) ($MN)
Table 145 RoW Mycoplasma Testing Market Outlook, By Other End Users (2014-2022) ($MN)